Skip to main content
Premium Trial:

Request an Annual Quote

Macrogen Clinical Laboratory Achieves CLIA Certification

NEW YORK (GenomeWeb News) – Korean genomics services firm Macrogen said today that its Rockville, Md.-based subsidiary has received CLIA certification.

Macrogen Clinical Laboratory, launched in late 2012, offers diagnostic testing for genetic diseases through clinical whole-exome sequencing and targeted sequencing, and provides a "total genomic solution" for the clinical and research area, its Medical Director Sechin Cho said in a statement. He added that the company will expand its services to include DNA chip-based neo-genome scanning and cancer diagnostic panels, as well as transcriptome sequencing.

Macrogen is based in Seoul, South Korea and is equipped with 30 next-generation sequencers from Illumina, Roche, and Life Technologies' Ion Proton business, it said.

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.